Phase 4 Completed N=60 Randomized Quadruple-blind Treatment

Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture

Postoperative Pain

Source: ClinicalTrials.gov NCT01719237 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2022

Primary outcomePrimary: Onset of Surgical Anesthesia — 16; 22; 9; 16 minutes

◆ Published Evidence

No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

A double blinded randomized controlled trial comparing the onset and duration of the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using a long acting local anesthestic (Ropivacaine) with a mixture of a long and short acting local anesthestic (Ropivacaine-Chloroprocaine Mixture).

Outcome Measures

Outcome	Result	p-value
PRIMARY Onset of Surgical Anesthesia	16; 22; 9; 16; 6; 10	—
SECONDARY Duration of Analgesia	566; 718	—

Eligibility Criteria

Inclusion Criteria

Patients who will be having a supraclavicular brachial plexus block as part of their anesthetic will be approached for possible inclusion in the study

Exclusion Criteria

patients who are pregnant,
have an ASA status of IV or greater,
neuropathy,
a cast or other impediment to performing a motor or sensory exam in the arm and hand,
patients under the age of 18,
long term opioid therapy (longer than 1 month),
history of opioid abuse and pseudocholinesterase deficiency

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01719237). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.